Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations. Looking ...

Michael Vaughan supports BCCI’s two-year ban on Harry Brook for withdrawing from IPL 2025, emphasizing that players were ...

Full Year 2024 Results Key Financial Results Revenue: US$37.3m (up 9.5% from FY 2023).

With its stock down 12% over the past three months, it is easy to disregard Marks and Spencer Group (LON:MKS). But ...

The MSCI World equity index snapped a four-week losing streak for a rise of 0.7%, the S&P 500 rose 0.5%, the Nasdaq eked out a gain of 0.17% - just avoiding its worst run since the 2022 bear market - ...

Risk Assets continue to struggle despite some gains in the S&P 500 and Dow Jones. It highlights investor concerns about US ...

The Company's financial results are presented in accordance with IFRS as issued by the IASB.

UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

The essential thrombocythemia market is on a growth trajectory, driven by increasing diagnosis rates, aging population ...

The Artisan International Small-Mid Fund portfolio outperformed the MSCI ACWI ex USA SMID Index in Q4 of 2024. Click here to ...

US biotech Rhythm Pharmaceuticals (Nasdaq: RYTM) has reacquired the rights to its obesity treatment Imcivree (setmelanotide) ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...